PDX Pharmaceuticals
PrivateLast Round
Grant
Sep 23, 2024
Total Funding Raised
$8.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PDX Pharmaceuticals is a biopharmaceutical company that develops next-generation combination immunotherapies for cancer using a novel nanotechnology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PDX Pharmaceuticals Comparables
Compare PDX Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lemonex Inc. | 79% | |
| Thalia Therapeutics PLC | 76% | |
| Sirnaomics | 74% |
PDX Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2024 | ||||
| Grant | Jul 6, 2023 | ||||
| Grant | Feb 21, 2023 | ||||
| Series A Extension | Feb 9, 2021 | ||||
| Series A | Jan 16, 2020 | ||||
Grant | May 1, 2017 |
Key People
Founding team and executive leadership
PDX Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Wayne D. Kuni & Joan E. Kuni Foundation | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 27, 5.8x the trailing average.
- Jan 20, 2026
Monthly visitors increased 289% MoM, reaching 3.5K.
PDX Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PDX Pharmaceuticals's valuation, stock price, and market status.
Is PDX Pharmaceuticals a public or private company?
PDX Pharmaceuticals is a private company.
What is the current stock price of PDX Pharmaceuticals?
PDX Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is PDX Pharmaceuticals worth (valuation)?
Valuation information for PDX Pharmaceuticals is not publicly available.
Can I buy PDX Pharmaceuticals stock?
PDX Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PDX Pharmaceuticals's last funding round?
PDX Pharmaceuticals's most recent funding round was Grant on September 23, 2024.
Who are the main investors in PDX Pharmaceuticals?
Key investors in PDX Pharmaceuticals include The Wayne D. Kuni & Joan E. Kuni Foundation.
Will PDX Pharmaceuticals IPO soon?
No public IPO plans have been announced for PDX Pharmaceuticals.
How can I track PDX Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PDX Pharmaceuticals's secondary market activity and sign up for updates.